Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
Person-Centered Quality Measurement and Management in a System for Addictions Treatment in New York State (Project 3)
for
Health Services Research
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 64
Code: NCT06408233
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Location: New York NY, Providence RI, Rochester NY, Raleigh NC,
Sponsor: Mirador Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07113522
Phase 2, Recruiting
Protocol CAUSE-03 / CHEETAH
for
Asthma
Location: New York NY, Boston MA, Washington D.C. DC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 6 - 17
Code: NCT06136091
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: New York NY, Long Island City NY, Hackensack NJ,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: New York NY, Philadelphia PA, Hershey PA, Boston MA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
for
Opioid Use Disorder
Location: New York NY
Sponsor: Rachel R. Luba
Sex: All
Age: 18 - 65
Code: NCT06726200
Early Phase 1, Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Location: New York NY, Lake Success NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876649
Recruiting
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
for
Soft Tissue Lesion
Location: New York NY, Wynnewood PA, Morgantown WV, Durham NC,
Sponsor: Galvanize Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05851430
Recruiting
Improving Medication Management in World Trade Center Responders
for
Polypharmacy
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 50+
Code: NCT07022990
Recruiting
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
for
High-risk Myelodysplastic Syndrome,
Location: New York NY, Philadelphia PA, Boston MA, Chicago IL,
Sponsor: Crossbow Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT06994676
Phase 1, Recruiting
The VENTOR Clinical Study
for
Cardiac Arrest (CA)
Location: Stony Brook NY
Sponsor: CoLabs Medical
Sex: All
Age: 18 - 70+
Code: NCT06759389
Recruiting
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for
Urothelial Carcinoma Bladder,
Location: New York NY, Glen Burnie MD, Pittsburgh PA,
Sponsor: Aktis Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07020117
Phase 1, Recruiting
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
for
Breast Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05438511
Recruiting
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
for
Glioblastoma, IDH-wildtype, Glioblastoma,
Location: New York NY, Providence RI, Cleveland OH, Durham NC,
Sponsor: Orbus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05879367
Phase 1, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Lake Success NY, East Brunswick NJ, Fairfax VA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase 1, Recruiting
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy